|
Alemtuzumab
|
Visite: 178
|
|
Altretamine
|
Visite: 362
|
|
Aminoglutetimide
|
Visite: 321
|
|
L'Acido 5-Aminolevulinico
|
Visite: 279
|
|
Idrossicarbamide
|
Visite: 187
|
|
Anastrozole
|
Visite: 347
|
|
Arsenico Triossido Di
|
Visite: 309
|
|
Asparaginasi
|
Visite: 302
|
|
Bevacizumab
|
Visite: 192
|
|
Bexarotene
|
Visite: 343
|
|
Bleomicina
|
Visite: 339
|
|
Busulfan
|
Visite: 301
|
|
Capecitabina
|
Visite: 321
|
|
Carboplatino
|
Visite: 367
|
|
Carmustina
|
Visite: 364
|
|
Cetuximab
|
Visite: 220
|
|
Ciclofosfamide
|
Visite: 208
|
|
Cisplatino
|
Visite: 215
|
|
La citarabina
|
Visite: 194
|
|
Cladribina
|
Visite: 211
|
|
Chlorambucil
|
Visite: 320
|
|
Chlormethinum
|
Visite: 334
|
|
Dacarbazina
|
Visite: 169
|
|
Dactinomicina
|
Visite: 221
|
|
Daunorubicina
|
Visite: 173
|
|
Docetaxel
|
Visite: 172
|
|
Doxorubicina
|
Visite: 346
|
|
Epirubucin
|
Visite: 166
|
|
Erlotinib
|
Visite: 172
|
|
Etoposide
|
Visite: 205
|
|
Exemestano
|
Visite: 231
|
|
Fluorouracile Topico Soluzione
|
Visite: 152
|
|
Fluorouracile
|
Visite: 225
|
|
Gemcitabina
|
Visite: 160
|
|
Idarubicina-Hcl
|
Visite: 202
|
|
Ifosfamide
|
Visite: 153
|
|
Melfalan
|
Visite: 158
|
|
Mercaptopurina
|
Visite: 198
|
|
Methotrexate
|
Visite: 252
|
|
Mitomicina
|
Visite: 258
|
|
Mitoxantrone
|
Visite: 160
|
|
Oxaliplatino
|
Visite: 140
|
|
Paclitaxel
|
Visite: 195
|
|
Pentostatina
|
Visite: 190
|
|
Procarbazina
|
Visite: 166
|
|
Rituximab
|
Visite: 217
|
|
Teniposide
|
Visite: 160
|
|
Tioguanina
|
Visite: 152
|
|
Tiotepa
|
Visite: 155
|
|
Trastuzumab
|
Visite: 191
|
|
Tretinoin Orale
|
Visite: 194
|
|
Vinblastina
|
Visite: 165
|
|
Vincristina
|
Visite: 161
|
|
Vinorelbine Tartrate
|
Visite: 180
|
|
Everolimus
|
Visite: 180
|
|
Imatinib Mesilato
|
Visite: 170
|
|
Nilotinib
|
Visite: 210
|
|
Dasatinib
|
Visite: 174
|
|
Pazopanib
|
Visite: 150
|
|
Ipilimumab
|
Visite: 149
|
|
Nivolumab
|
Visite: 197
|
|
Brentuximab Vedotin
|
Visite: 181
|